Cost-effectiveness analysis of tenofovir disoproxil fumarate for treatment of chronic hepatitis B in China
Crossref DOI link: https://doi.org/10.1007/s12072-016-9741-6
Published Online: 2016-06-07
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ke, Weixia
Zhang, Chi
Liu, Li
Gao, Yanhui
Yao, Zhenjiang
Ye, Xiaohua
Zhou, Shudong
Yang, Yi
Funding for this research was provided by:
National Natural Science Foundations of China (81302493)
License valid from 2016-06-07